Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jerill Thorpe"'
Autor:
Sarah Alice Long, Virginia S. Muir, Britta E. Jones, Valerie Z. Wall, Alyssa Ylescupidez, Anne M. Hocking, Stephan Pribitzer, Jerill Thorpe, Bryce Fuchs, Alice E. Wiedeman, Megan Tatum, Katharina Lambert, Hannes Uchtenhagen, Cate Speake, Bernard Ng, Alexander T. Heubeck, Troy R. Torgerson, Adam K. Savage, Michael A. Maldonado, Neelanjana Ray, Vadim Khaychuk, Jinqi Liu, Peter S. Linsley, Jane H. Buckner
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Exhausted CD8 T cells (TEX) are associated with worse outcome in cancer yet better outcome in autoimmunity. Building on our past findings of increased TIGIT+KLRG1+ TEX with teplizumab therapy in type 1 diabetes (T1D), in the absence of treatment we f
Externí odkaz:
https://doaj.org/article/848afa4859044e9fb280078686f378e7
Autor:
Georg Schett, Fan Wu, Nikolay Delev, Ruth Salmon, Jerill Thorpe, Amitkumar Mehta, Tatyana Feldman, Jeremy Abramson, Boyu Hu, Fabien Müller, Ashley Koegel, Divya Varun, Alison Maier, David Kugler, Matthew Westoby
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/ac8828bfb2494c95a4e57d7e20c595b5
Autor:
Julie Rytlewski, Leanne Peiser, Jerill Thorpe, Heidi Gillenwater, Ken Ogasawara, Yeonhee Kim, Diana Shpektor, Eniko Papp
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/1603585596764915b3aaf112d600f635
Autor:
Ivana Durinovic-Belló, Vivian H Gersuk, Chester Ni, Rebecca Wu, Jerill Thorpe, Nicholas Jospe, Srinath Sanda, Carla J Greenbaum, Gerald T Nepom
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e98074 (2014)
Fate determination for autoreactive T cells relies on a series of avidity-dependent interactions during T cell selection, represented by two general types of signals, one based on antigen expression and density during T cell development, and one base
Externí odkaz:
https://doaj.org/article/5c1f3d12ff434afd83a179e2502e4265
Autor:
Alison, Sehgal, Daanish, Hoda, Peter A, Riedell, Nilanjan, Ghosh, Mehdi, Hamadani, Gerhard C, Hildebrandt, John E, Godwin, Patrick M, Reagan, Nina, Wagner-Johnston, James, Essell, Rajneesh, Nath, Scott R, Solomon, Rebecca, Champion, Edward, Licitra, Suzanne, Fanning, Neel, Gupta, Ronald, Dubowy, Aleco, D'Andrea, Lei, Wang, Ken, Ogasawara, Jerill, Thorpe, Leo I, Gordon
Publikováno v:
The Lancet Oncology. 23:1066-1077
Patients with relapsed or refractory large B-cell lymphoma after first-line treatment who are not intended for haematopoietic stem-cell transplantation (HSCT) have poor outcomes and limited treatment options. We assessed the antitumour activity and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7048a30eddf5ad18755f1aba03ca478
https://doi.org/10.1016/s1470-2045(22)00339-4
https://doi.org/10.1016/s1470-2045(22)00339-4
Autor:
Brian A. Fox, Kathryn J. Newhall, Candice McCoy, Jeremy S. Abramson, Yeonhee Kim, Jerill Thorpe, David J. Reiss, Seamus P. Ragan, N. Eric Olson
Supplementary Methods; Supplementary Figures S1-S9; Supplementary Tables S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191b83d855590b5ceebe2e4af6e82262
https://doi.org/10.1158/1535-7163.22523172.v1
https://doi.org/10.1158/1535-7163.22523172.v1
Autor:
Luciano J. Costa, Shaji K Kumar, Shebli Atrash, Michaela Liedtke, Gurbakhash Kaur, Benjamin A. Derman, P. Leif Bergsagel, Sham Mailankody, Philip L. McCarthy, Josiana Limones, Yanping Chen, Sharmila Das, Jerill Thorpe, Jonathan Cacciatore, Garnet Navarro, Ashley K Koegel, Michael R. Burgess, Kristen Hege, Shambavi Richard
Publikováno v:
Blood. 140:1360-1362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a00c80551ced240eb63809c3aab0756c
https://doi.org/10.1182/blood-2022-160038
https://doi.org/10.1182/blood-2022-160038
Autor:
N. Eric Olson, Seamus P. Ragan, David J. Reiss, Jerill Thorpe, Yeonhee Kim, Jeremy S. Abramson, Candice McCoy, Kathryn J. Newhall, Brian A. Fox
Publikováno v:
Molecular cancer therapeutics.
In the TRANSCEND NHL 001 study, 53% of patients with relapsed/refractory large B-cell lymphoma (LBCL) treated with lisocabtagene maraleucel (liso-cel) achieved a complete response (CR). To determine characteristics of patients who did and did not ach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac7ef95bf2f8a484af9f4a768e04db7
https://pubmed.ncbi.nlm.nih.gov/36595660
https://pubmed.ncbi.nlm.nih.gov/36595660
Autor:
Tanya Siddiqi, William G. Wierda, Lin Yang, Scott R. Solomon, Jerill Thorpe, Kathleen A. Dorritie, Deborah M. Stephens, Ken Ogasawara, Heidi H. Gillenwater, Lucy Gong, Javier Munoz
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a87e28e526d08b343fdeb12bb973eba6
https://doi.org/10.1002/hon.86_2879
https://doi.org/10.1002/hon.86_2879
Autor:
Tanya Siddiqi, Lin Yang, Jacob D. Soumerai, Jon E. Arnason, Deborah M. Stephens, Lucy Gong, Heidi H. Gillenwater, Peter A. Riedell, Ken Ogasawara, Kathleen A. Dorritie, William G. Wierda, Jerill Thorpe, Thomas J. Kipps
Publikováno v:
Blood. 139(12)
Bruton tyrosine kinase inhibitors (BTKi) and venetoclax are currently used to treat newly diagnosed and relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). However, most patients eventually develop resistance to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ccc7eab535e49979eed30bf8bcfc938
https://pubmed.ncbi.nlm.nih.gov/35323881
https://pubmed.ncbi.nlm.nih.gov/35323881